• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Zimmer Holdings (NY:ZBH)

    87.16 +87.15 (+979225.84%)
    Official Closing Price Updated: 7:00 PM EDT, Jun 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Zimmer Holdings

    News headline image
    Bragar Eagel & Squire, P.C. Is Investigating Gauzy and Zimmer Biomet and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay & Murray LLP
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery
    From Monogram Technologies Inc.
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Monogram Technologies Inc. (Nasdaq - MGRM), Veritex Holdings, Inc. (Nasdaq - VBTX), ESSA Pharma Inc. (Nasdaq - EPIX), Waters Corporation (NYSE - WAT)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
    From Monogram Technologies Inc.
    Via GlobeNewswire
    News headline image
    Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
    From Treace Medical Concepts, Inc.
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (Nasdaq - ACCD), Paragon 28, Inc. (NYSE - FNA), Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
    Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs. 
    Via MarketBeat
    News headline image
    Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
    Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia 
    Via MarketBeat
    News headline image
    Medical Technology Stock Benefits from Rising Acute Care Demand
    Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. 
    Via MarketBeat
    Topics Supply Chain
    News headline image
    Why Intuitive Surgical Stock is Dominating the Medical Sector
    Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However 
    Via MarketBeat
    News headline image
    Intuitive Surgical Leads the Robotic Surgery Movement
    Intuitive Surgical is the pioneer in robotic-assisted surgery, investors hope the fifth generation of its da Vinci system can push ISRG stock higher 
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    Hidden gems: 3 undervalued stocks with a unique competitive edge
    Etsy, International Flavors & Fragrances and Zimmer Biomet are undervalued stocks with unique market advantages. Patient investors may find opportunities here. 
    Via MarketBeat
    News headline image
    Is the Ozempic-Driven DexCom Selloff Overdone?
    Has glucose monitor maker DexCom corrected too much on fears of lost sales due to weight loss and diabetes drugs made by Novo Nordisk and Eli Lilly? 
    Via MarketBeat
    News headline image
    3 Undervalued Healthcare Stocks to Watch as Sector Struggles
    As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth. 
    Via MarketBeat
    News headline image
    DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
    DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
    Via MarketBeat
    News headline image
    Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
    Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. 
    Via MarketBeat
    News headline image
    Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher
    Shockwave got a 10.64% jolt on a proposed Medicare change that could up the usage of its gear. Other medical product makers are forming bullish consolidations. 
    Via MarketBeat
    News headline image
    Zimmer Biomet Beats on Earnings, Growth May be Priced In
    Zimmer Biomet stock is gaining after beating expectations. However, ZBH stock was fairly valued before earnings meaning investors may need to wait on analysts 
    Via MarketBeat
    News headline image
    Is Zimmer Biomet a Buy Ahead of Earnings?
    Zimmer will report Q4'22 earnings this week. The question on people's minds is if it's a buy prior to this announcement being made. 
    Via MarketBeat
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.